Barcelona

• Phase 2 Study of iadademstat for the treatment of patients with essential thrombocythemia resistant/intolerant to hydroxyurea. Recruiting
  2025-523864-19-00 4 2026-04-23 Essential Thrombocythemia
• A clinical trial of sacituzumab tirumotecan to treat urothelial cancer (MK-2870-031) Recruiting
  2024-520014-22-00 5 2026-04-22 Locally advanced/metastatic urothelial carcinoma
• A clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosi … Recruiting
  2025-521546-23-00 5 2026-04-21 Secondary progressive multiple sclerosis
• Phase 1, Randomized, Open-label, Single center study to evaluate Pharmacokinetic and Bioequivalence of Levonorgestrel Vaginal Delivery Syste … Recruiting
  2025-524330-25-00 3 2026-04-21 No medical condition
• Non-inferiority study of frexalimab subcutaneous administration compared to intravenous administration in adult participants with multiple s … Recruiting
  2024-519304-28-00 5 2026-04-20 Multiple Sclerosis
• A clinical study to investigate the efficacy and safety of an investigational combination therapy with BNT324 and BNT327 in patients with ad … Recruiting
  2024-520238-31-01 9 2026-04-20 Advanced Lung Cancer
• A Phase I Interventional Open-Label, Non-Randomized Dose-Escalation Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacody … Recruiting
  2024-516660-28-01 1 2026-04-17 Locally advanced, recurrent, or metastatic breast, gastric, endometria
• A Phase 3 Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children with Short Statur … Recruiting
  2025-523079-44-00 5 2026-04-15 Turner Syndrome (TS)
• A Phase 1a/1b Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Antitumor Activity of BG-75202, … Recruiting
  2025-523553-34-00 1 2026-04-15 Advanced and Metastatic Solid tumors
• Study to Assess the Ability of ONL1204 to Slow the Progression of Atrophic Age-related Macular Degeneration Recruiting
  2024-513174-22-00 4 2026-04-14 Atrophic Age-related Macular Degeneration (AMD)
• A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma Recruiting
  2025-524542-10-00 4 2026-04-14 Endometrial cancer
• A Phase 3 Study to Evaluate AOC 1020 in Participants with FSHD Recruiting
  2025-521012-18-00 5 2026-04-13 Facioscapulohumeral Muscular Dystrophy (FSHD)
• Phase 3 Study of Barzolvolimab in Participants with Cold Induced Urticaria and Symptomatic Dermographism Recruiting
  2025-522583-32-00 5 2026-04-13 Cold-Induced Urticaria and Symptomatic Dermographism
• A trial to learn how safe the combination of rilvegostomig and chemotherapy is and how well it works compared to durvalumab and chemotherapy … Recruiting
  2025-523085-24-00 5 2026-04-13 Biliary Tract Cancer
• Study of ART6043 in Advanced/​Metastatic Solid Tumors Patients Recruiting
  2023-509220-17-00 7 2026-04-10 Metastatic solid tumors
• A Phase 1a/1b Open-Label Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of BBO-8520 in Subjects with Advanced KRA … Recruiting
  2024-512515-45-01 1 2026-04-10 Non-Small Cell Lung Cancer
• A Study of Eloralintide (LY3841136) in Participants with Obesity or Overweight, and Type 2 Diabetes (ENLIGHTEN-2) Recruiting
  2025-523658-15-00 5 2026-04-10 Obesity
• Exploring the anti-aging effects of Metformin in COPD Recruiting
  2025-520972-24-00 5 2026-04-08 Chronic Obstructive Pulmonary Disease (COPD)
• A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Dose Comparison and Exploratory Efficacy Study of Orally Administered SAT-3247 in A … Recruiting
  2025-522522-13-01 4 2026-04-08 Duchenne muscular dystrophy
• Trial to Evaluate the Safety and Preliminary Efficacy of GEN1079 in Participants with Advanced Solid Tumors Recruiting
  2025-523931-21-00 1 2026-04-07 Advanced Malignant Solid Tumors
• A trial to learn how effective and safe datopotamab deruxtecan (Dato-DXd) is compared to docetaxel and how well Dato-DXd works in adults wit … Recruiting
  2024-520101-39-00 5 2026-04-01 TROP2 NMR-positive advanced or metastatic non-squamous non-small cell
• Donidalorsen Treatment in Children with Hereditary Angioedema Recruiting
  2025-523499-22-00 5 2026-04-01 Hereditary Angioedema (HAE)
• Phase 1 open label trial of MST-0312 alone and in combination in subjects with solid malignancies Recruiting
  2025-524446-10-00 1 2026-04-01 Solid Malignancies
• A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination with Atezolizumab … Recruiting
  2024-517490-24-00 4 2026-03-31 Small Cell Lung Cancer

Showing 649–672 of 3,391 trials